TIMP‐2, known as tissue inhibitor of metalloproteinase 2, is differentially expressed in many tumours, including lung, breast, gastric, colorectal and cervical cancers [21, 22, 23, 24, 25], which also indicates that it may also have different expression levels in tumour patients. Here, TIMP2 is linked to cervical cancer.